Akcea Therapeutics, Inc. Restructuring Charges
Akcea Therapeutics, Inc. reported Restructuring Charges of $1.89 million for the 12-month period ending 2018-12-31, per its 10-K filed 2020-03-02.
Discontinued › Expense Statement › Operating Expenses
us-gaap:RestructuringCharges · last filed 2020-03-02
- Akcea Therapeutics, Inc. restructuring charges for the quarter ending 2018-12-31 was $0.00.
- Akcea Therapeutics, Inc. restructuring charges for the quarter ending 2018-09-30 was $1.90M.
- Akcea Therapeutics, Inc. restructuring charges for fiscal 2018 was $1.89M.
| Period end | Restructuring Charges 3 month | Restructuring Charges 6 month | Restructuring Charges 9 month | Restructuring Charges 12 month |
|---|---|---|---|---|
| 2018-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-02 | $1.90M derived: sum of 2 quarters · filed 2020-03-02 | $1.89M 10-K · filed 2020-03-02 | |
| 2018-09-30 | $1.90M 10-Q · filed 2018-11-06 | $1.89M 10-Q · filed 2018-11-06 |